A randomized, phase 2/3 clinical trial investigating RP2 plus nivolumab vs ipilimumab plus nivolumab in immune checkpoint inhibitor-naïve patients with metastatic uveal melanoma.

A post on inventcures.github.io, published 30 September 2026, has not been cited by any blog yet (corpus.blog, measured 9 October 2026).

A record is what was published and who pointed at it. The text of the post is not held here: read it at the source, or at its Wayback capture.